Hanafusa, Norio
Abe, Masanori
Joki, Nobuhiko
Hoshino, Junichi
Taniguchi, Masatomo
Kikuchi, Kan
Hasegawa, Takeshi
Goto, Shunsuke
Ogawa, Tetsuya
Kanda, Eiichiro
Nakai, Shigeru
Naganuma, Toshihide
Miura, Kenichiro
Wada, Atsushi
Takemoto, Yoshiaki
Article History
Received: 14 April 2025
Accepted: 2 June 2025
First Online: 1 July 2025
Declarations
:
: The JSDT Ethics Committee approved the JRDR survey (approval no. 1). The aims of the JSDT Renal Data Registry were explained in detail to the participating patients via the dialysis facilities. The need for informed consent was waived in view of the data having already been recorded before the survey, the noninterventional nature of the research, and the anonymity of the data analyzed. Therefore, there was no risk to the privacy of the dialysis facilities or their patients. The data presented in the current manuscript do not contain any images, videos, or voice recordings that might identify an individual patient.
: Not applicable.
: The Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry (JRDR) was approved by the Japanese Society for Dialysis Therapy ethics committee. It was registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry on September 10, 2020 and in the UMIN clinical trials registration system (UMIN000018641).
: Masanori Abe MD is the deputy editor of this journal. Norio Hanafusa MD is an associate editor of this journal. Tetsuya Ogawa MD is an editorial board member of this journal. Eiichiro Kanda MD is a statistic advisory board member of this journal.